WO2012162660A3 - Methods using dna methylation for identifying a cell or a mixture of cells for prognosis and diagnosis of diseases, and for cell remediation therapies - Google Patents
Methods using dna methylation for identifying a cell or a mixture of cells for prognosis and diagnosis of diseases, and for cell remediation therapies Download PDFInfo
- Publication number
- WO2012162660A3 WO2012162660A3 PCT/US2012/039699 US2012039699W WO2012162660A3 WO 2012162660 A3 WO2012162660 A3 WO 2012162660A3 US 2012039699 W US2012039699 W US 2012039699W WO 2012162660 A3 WO2012162660 A3 WO 2012162660A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cell
- cells
- methods
- identifying
- mixture
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/10—Ploidy or copy number detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/30—Unsupervised data analysis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Analytical Chemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Molecular Biology (AREA)
- Data Mining & Analysis (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioethics (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Software Systems (AREA)
- Evolutionary Computation (AREA)
- Artificial Intelligence (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Methods using DNA Methylation arrays are provided for identifying a cell or mixture of cells and for quantification of alterations in distribution of cells in blood or in tissues, and for diagnosing, prognosing and treating disease conditions, particularly cancer. The methods use fresh and archival samples.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2869295A CA2869295A1 (en) | 2011-05-25 | 2012-05-25 | Methods using dna methylation for identifying a cell or a mixture of cells for prognosis and diagnosis of diseases, and for cell remediation therapies |
EP12789375.8A EP2714933A4 (en) | 2011-05-25 | 2012-05-25 | Methods using dna methylation for identifying a cell or a mixture of cells for prognosis and diagnosis of diseases, and for cell remediation therapies |
US14/089,398 US20140178348A1 (en) | 2011-05-25 | 2013-11-25 | Methods using DNA methylation for identifying a cell or a mixture of cells for prognosis and diagnosis of diseases, and for cell remediation therapies |
US15/271,909 US10619211B2 (en) | 2011-05-25 | 2016-09-21 | Methods using DNA methylation for identifying a cell or a mixture of cells for prognosis and diagnosis of diseases, and for cell remediation therapies |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161489883P | 2011-05-25 | 2011-05-25 | |
US61/489,883 | 2011-05-25 | ||
US201161509644P | 2011-07-20 | 2011-07-20 | |
US61/509,644 | 2011-07-20 | ||
US201261585892P | 2012-01-12 | 2012-01-12 | |
US61/585,892 | 2012-01-12 | ||
US201261619663P | 2012-04-03 | 2012-04-03 | |
US61/619,663 | 2012-04-03 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/089,398 Continuation-In-Part US20140178348A1 (en) | 2011-05-25 | 2013-11-25 | Methods using DNA methylation for identifying a cell or a mixture of cells for prognosis and diagnosis of diseases, and for cell remediation therapies |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012162660A2 WO2012162660A2 (en) | 2012-11-29 |
WO2012162660A3 true WO2012162660A3 (en) | 2013-03-28 |
Family
ID=47218125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2012/039699 WO2012162660A2 (en) | 2011-05-25 | 2012-05-25 | Methods using dna methylation for identifying a cell or a mixture of cells for prognosis and diagnosis of diseases, and for cell remediation therapies |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2714933A4 (en) |
CA (1) | CA2869295A1 (en) |
WO (1) | WO2012162660A2 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9561006B2 (en) * | 2008-10-15 | 2017-02-07 | The United States Of America As Represented By The Secretary Of The Navy | Bayesian modeling of pre-transplant variables accurately predicts kidney graft survival |
EP3382033B1 (en) * | 2017-03-30 | 2020-08-05 | Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen | Method for determining blood counts based on dna methylation |
DE102017125019B4 (en) | 2017-10-25 | 2019-10-17 | Epiontis Gmbh | PDCD1 as an epigenetic marker for the identification of immune cells, in particular PD1 + cells |
DE102017125013B4 (en) | 2017-10-25 | 2019-10-17 | Epiontis Gmbh | MCC as an epigenetic marker for the identification of immune cells, in particular basophilic granulocytes |
DE102017125150B4 (en) | 2017-10-26 | 2019-10-10 | Epiontis Gmbh | Endosialin (CD248) as an epigenetic marker for the identification of immune cells, in particular naïver CD8 + T cells |
DE102017125335B4 (en) | 2017-10-27 | 2019-10-17 | Epiontis Gmbh | Amplicon region as an epigenetic marker for the identification of immune cells, especially non-classical monocytes |
DE102017126248B4 (en) | 2017-11-09 | 2019-10-17 | Epiontis Gmbh | ERGIC1 as epigenetic marker for the identification of immune cells, in particular monocytic myeloid-derived suppressor cells (mMDSCs) |
DE102018112644B4 (en) | 2018-05-25 | 2020-06-10 | Epiontis Gmbh | CXCR3 as an epigenetic marker for the identification of inflammatory immune cells, in particular CD8 + memory T cells |
EP3818179B1 (en) | 2018-07-05 | 2023-07-19 | Precision for Medicine GmbH | Epigenetic method to detect and distinguish ipex and ipex-like syndromes, in particular in newborns |
DE102020108560B4 (en) | 2020-03-27 | 2022-03-03 | Precision For Medicine Gmbh | CBX6 as an epigenetic marker for the identification of immune cells, especially memory B cells |
DE102020111423B4 (en) | 2020-04-27 | 2022-03-03 | Precision For Medicine Gmbh | MYH11/NDE1 region as an epigenetic marker for the identification of endothelial progenitor cells (EPCs) |
AU2021400488A1 (en) | 2020-12-14 | 2023-06-22 | Regeneron Pharmaceuticals, Inc. | Methods of treating metabolic disorders and cardiovascular disease with inhibin subunit beta e (inhbe) inhibitors |
CN114703284A (en) * | 2022-04-15 | 2022-07-05 | 北京莱盟君泰国际医疗技术开发有限公司 | Blood free DNA methylation quantitative detection method and application thereof |
CN116312794B (en) * | 2023-01-09 | 2023-11-14 | 哈尔滨医科大学 | Methylation sample clustering method fused with single cell analysis method |
CN116949156B (en) * | 2023-09-19 | 2023-12-08 | 美迪西普亚医药科技(上海)有限公司 | Analysis method for detecting human T cells in general way based on nucleic acid variants |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070269823A1 (en) * | 2006-02-28 | 2007-11-22 | Jochen Huehn | Detection and quality control of regulatory T cells through DNA-methylation analysis of the Foxp3 gene |
-
2012
- 2012-05-25 CA CA2869295A patent/CA2869295A1/en not_active Abandoned
- 2012-05-25 EP EP12789375.8A patent/EP2714933A4/en not_active Withdrawn
- 2012-05-25 WO PCT/US2012/039699 patent/WO2012162660A2/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070269823A1 (en) * | 2006-02-28 | 2007-11-22 | Jochen Huehn | Detection and quality control of regulatory T cells through DNA-methylation analysis of the Foxp3 gene |
Non-Patent Citations (3)
Title |
---|
KERKEL, K. ET AL.: "Altered DNA methylation in leukocytes with Trisomy 21", PLOS GENETICS, vol. 6, November 2010 (2010-11-01), pages E1001212, XP055139128 * |
MARTIN-SUBERO, J. ET AL.: "A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms", PLOS ONE, vol. 4, no. 9, September 2009 (2009-09-01), pages E6986, XP055139130 * |
WANG, X. ET AL.: "Obesity related methylation changes in DNA of peripheral blood leukocytes", BMC MEDICINE, vol. 8, no. 87, 21 December 2010 (2010-12-21), XP021089557 * |
Also Published As
Publication number | Publication date |
---|---|
EP2714933A2 (en) | 2014-04-09 |
EP2714933A4 (en) | 2014-12-31 |
CA2869295A1 (en) | 2012-11-29 |
WO2012162660A2 (en) | 2012-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012162660A3 (en) | Methods using dna methylation for identifying a cell or a mixture of cells for prognosis and diagnosis of diseases, and for cell remediation therapies | |
WO2008146309A3 (en) | Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment | |
EP2569453A4 (en) | Nucleic acid isolation methods | |
EP4303584A3 (en) | Methods for detecting signatures of disease or conditions in bodily fluids | |
WO2010004591A3 (en) | Genetic variants for breast cancer risk assessment | |
WO2011087709A3 (en) | Eml4-alk translocations in lung cancer | |
WO2012031008A3 (en) | Cancer-related biological materials in microvesicles | |
WO2012174256A3 (en) | Dna methylation profiles in cancer | |
WO2010135692A3 (en) | Mirna biomarkers of prostate disease | |
WO2012167145A3 (en) | Genome-scale analysis of aberrant dna methylation in colorectal cancer | |
EP2227691A4 (en) | Method for diagnosing lung cancers using gene expression profiles in peripheral blood mononuclear cells | |
WO2008108803A3 (en) | Immune cell biosensors and methods of using same | |
MX2013000917A (en) | Methods of detecting diseases or conditions using phagocytic cells. | |
WO2007039290A3 (en) | Methods and nucleic acids for the analysis of gene expression associated with the prognosis of cell proliferative disorders | |
WO2008117314A3 (en) | Genetic variants on chr2 and chr16 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment | |
BRPI0817008A2 (en) | oligonucleotide, primer or probe, primer pair, kit, methods for detecting the presence and / or amount of the unmethylated and methylated mage-a3 gene in a DNA-containing sample to diagnose cancer or cancer predisposition or cancer predisposition, to identify and / or select a suitable patient for treatment with a mage-a3 immunotherapeutic, to predict the likelihood of successful cancer treatment, to select an appropriate cancer treatment regimen, to treat cancer in a patient, to treat a patient susceptible to recurrence of a tumor expressing mage-a3, and use of a composition | |
WO2011106541A3 (en) | Diagnostic methods involving loss of heterozygosity | |
WO2011153545A3 (en) | Gene expression signature as a predictor of chemotherapeutic response in breast cancer | |
WO2017027391A3 (en) | Genetic abnormalities in plasma cell dyscrasias | |
EP2513340A4 (en) | Mean dna copy number of chromosomal regions is of prognostic significance in cancer | |
WO2009061800A3 (en) | Methods and compositions for diagnostic use in cancer patients | |
WO2011112903A3 (en) | Quantitative rt-pcr detection for genes involved in epithelial mesenchymal transition in peripheral blood of breast cancer patients | |
WO2012154567A3 (en) | Human invasion signature for prognosis of metastatic risk | |
WO2012027483A3 (en) | Defining diagnostic and therapeutic targets of conserved free floating fetal dna in maternal circulating blood | |
EP2405959A4 (en) | Methods, apparatuses, and kits for introducing genetic material into living cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12789375 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2869295 Country of ref document: CA |